4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-22-001527
Director bought 3,947 shares at $19.00 ($74,993)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FONTEYNE PAUL R. Director | 2022-01-06 | Purchase | +3,947 | $19.00 | $74,993 | 3,947 | D |
| Derivatives | |||||||
| FONTEYNE PAUL R. Director | 2022-01-06 | Grant or award · Stock Option (Right to Buy) | +8,400 | 8,400 | D | ||
| Open-market purchases · 3,947 sh · avg $19.00 · $74,993 | |||||||
Loading xslF345X03/doc4.xml…